Top Markets
Coin of the day
Hemostemix Inc. Hemostemix Inc.

Hemostemix Inc.

HEM
Clasificación en acciones #32158
Hemostemix Inc., a clinical stage biotechnology company, develops,... Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which is in Phase II clinical trial for the treatment of vascular diseases, such as peripheral arterial disease, angina pectoris, and ischemia, as well as heart failure, ischemic and dilated cardiomyopathy, chronic limb threatening ischemia, vascular dementia, and brain function. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.
Precio por acción
$0.05504527
Última sincronización: 2026-08-17
Capitalización bursátil
$10.89M
Cambio (1 día)
15.38%
Cambio (1 año)
-10.64%
País
CA
Comercio Hemostemix Inc. (HEM)

Categoría

Historial del precio de la acción de Hemostemix Inc. (HEM)
Precio más alto de cierre: $0.05 el 2026-08-01

Precio más bajo de cierre: $13.17 el 2014-11-01
Historial del precio de la acción de Hemostemix Inc. desde 2014 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -3.76%
2025 16.47%
2024 0.85%
2023 -52.75%
2022 -7.37%
2021 -60.16%
2020 105.00%
2019 -89.61%
2018 12.43%
2017 -27.92%
2016 -79.94%
2015 -39.73%
2014 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$515.58 32.24%
US
$992.01 50.00%
NL
$112.11 -36.37%
AU
$736.64 6.99%
CH
$1.06K -6.98%
KR